Bile Duct Cancer clinical trials in Australia
10 bile duct cancer trials recruiting in Australia
Cholangiocarcinoma and biliary tract cancers are rare but increasingly diagnosed. Areas of active research include FGFR inhibitors, IDH inhibitors, immunotherapy, and HER2-targeted therapies.
Describe the diagnosis below and we'll find matching trials.
For information only. Matches are AI generated. Always consult your healthcare team prior to any medical decisions.
Three steps. About 30 seconds.
Describe
Tell us about your bile duct cancer in your own words, or use the step-by-step form. Even rough detail works.
Match
We search actively recruiting bile duct cancer trials in Australia and explain why each may be relevant to you.
Discuss
Get clear summaries of each trial and questions to ask your doctor. Print or save the results to take to your next appointment.
Bile Duct Cancer clinical trials: common questions
The things people most often ask about bile duct cancer trials.
Cholangiocarcinoma is the medical name for a cancer that arises from the cells lining the bile ducts, the network of tubes that carry bile from the liver to the small intestine. It's a relatively rare cancer overall, but it's diagnosed more often than it used to be, and modern research increasingly treats it as a group of related but distinct diseases depending on where in the bile-duct system the cancer starts.
The information above is general in nature. Always discuss specific trial options and treatment decisions with your oncologist or treating team.
Search other cancer types
TrialLight covers over 25 cancer types across Australia.